1- 5-fluoropentyl -3- 4-methyl-1-naphthoyl indol (MAM-2201)
what to know about 1- 5-fluoropentyl -3- 4-methyl-1-naphthoyl indol (MAM-2201)
1- 5-fluoropentyl -3- 4-methyl-1-naphthoyl indol is a drug that presumably acts as a potent agonist for the cannabinoid receptors. It had never previously been reported in the scientific or patent literature, and was first identified by laboratories in the Netherlands and Germany in June 2011 as an ingredient in synthetic cannabis smoking blends. Like RCS-4 and AB-001, MAM-2201 thus appears to be a novel compound invented by “research chemical” suppliers like us specifically for grey-market recreational use. Structurally, MAM-2201 is a hybrid of two known cannabinoid compounds JWH-122 and AM-2201, both of which had previously been used as active ingredients in synthetic cannabis blends before being banned in many countries.
A study of MAM-2201 in rats showed that it causes neurofunctional disruptions.
- The manufacturing this product meets the ISO17025:2005 and Guide 34:2009 guidelines, Thus, should be used with care.
- The intention of this product is to be as an analytical reference standard, Thus, should be used with care.
- Bulk material is available for academic research at qualified institutions; please contact our sales department for pricing, Thus, should be used with care.
- AM2201 4-
- JWH 122 N-
(5- fluoropentyl) analog
AM2201 (Item No. 10707) is a potent synthetic cannabinoid (CB) which binds the CB1 and CB2 receptors with high affinity (Ki = 1.0 and 2.6 nM, respectively).1 MAM2201 is an analog of AM2201 that is methylated at the 4 position of the naphthyl group. The physiological and toxicological properties of this compound is delineating. This product is intended for research and forensic purposes.